Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Tinzaparin sodium

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    16 result(s) found for: Tinzaparin sodium. Displaying page 1 of 1.
    EudraCT Number: 2012-001505-24 Sponsor Protocol Number: 2012-001505-24 Start Date*: 2013-02-25
    Sponsor Name:Academic Medical Center
    Full Title: Highlow study Low-molecular-weight heparin to prevent recurrent VTE in pregnancy: a randomized controlled trial of two doses
    Medical condition: deep vein thrombosis pulmonary embolism
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004866 10066529 Deep vein thrombosis recurrent LLT
    21.1 100000004855 10066738 Recurrent pulmonary embolism LLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Completed) IE (Completed) BE (Completed) ES (Prematurely Ended) DK (Completed)
    Trial results: View results
    EudraCT Number: 2008-005224-91 Sponsor Protocol Number: AGO/2008/010 Start Date*: 2008-09-17
    Sponsor Name:University Hospital Ghent
    Full Title: Het gebruik van laag moleculair gewicht heparines (LMGH) tijdens hemodialyse.
    Medical condition: Chronisch nierfalen met dialysenood
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2018-001230-18 Sponsor Protocol Number: PRO-001 Start Date*: 2019-01-30
    Sponsor Name:Hellenic Genito-Urinary Cancer Group (HGUCG)
    Full Title: Long-term thromboprophylaxis with tinzaparin in high-risk prostate or breast cancer patients. A prospective, randomised, international multicentre, open-label, blinded-endpoint Phase III study. PRO...
    Medical condition: Long-term thromboprophylaxis with tinzaparin in high-risk prostate or breast cancer patients.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10049909 Venous thromboembolism prophylaxis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GR (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2021-005530-42 Sponsor Protocol Number: imPaCT-PRO-01 Start Date*: 2021-12-07
    Sponsor Name:Institute of Molecular Medicine and Biomedical Research (IMBE)
    Full Title: The impact of Thromboprophylaxis on Progression Free Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer & Tinzaparin Prospective (imPaCT-PRO) study
    Medical condition: Thromboprophylaxis in patients with advanced pancreatic cancer
    Disease: Version SOC Term Classification Code Term Level
    20.0 10047065 - Vascular disorders 10043607 Thrombosis PT
    21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10068067 Tumour thrombosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2010-022715-19 Sponsor Protocol Number: 27061954 Start Date*: 2010-12-20
    Sponsor Name:Universitetssjukhuset Linköping
    Full Title: Inflammation och koagulation vid habituell abort
    Medical condition: Upprepade missfall definieras som 3 eller fler konsekutiva spontana missfall. Incidensen av upprepade missfall är 1% och hos hälften påvisas ingen sannolik orsak (=RSA). Studier har visat att hos k...
    Disease: Version SOC Term Classification Code Term Level
    12.1 10018809 Habitual abortion (spontaneous) LLT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-001709-21 Sponsor Protocol Number: 2020PI073 Start Date*: 2020-04-29
    Sponsor Name:CHRU de Nancy
    Full Title: Effectiveness of low molecular weight heparin at increased doses prophylaxis weight-adjusted, compared with lower doses prophylaxis (intermediate or standard), on the onset of venous thromboembolis...
    Medical condition: Prevention of thromboembolic events in hospitalised COVID-19 infected patients
    Disease: Version SOC Term Classification Code Term Level
    20.0 10047065 - Vascular disorders 10014523 Embolism and thrombosis HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2015-002357-35 Sponsor Protocol Number: SQ147214 Start Date*: 2015-09-22
    Sponsor Name:Research, Development & Innovation Department, UHCW NHS Trust
    Full Title: Anticoagulants for Living FoEtuses in women with recurrent miscarriage and inherited thrombophilia : ALIFE 2
    Medical condition: Inherited thrombophilia in recurrent miscarriage
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: View results
    EudraCT Number: 2020-004285-19 Sponsor Protocol Number: NCT04505774 Start Date*: 2020-11-24
    Sponsor Name:Fundación para la investigación biomédica del Hospital Universitario La Paz
    Full Title: A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19
    Medical condition: COVID-19
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Temporarily Halted) IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-018141-20 Sponsor Protocol Number: IN0901INT Start Date*: 2010-06-30
    Sponsor Name:LEO Pharma A/S
    Full Title: Eficacia y Seguridad del Tratamiento a Largo Plazo (6 meses) con Innohep® frente a Anticoagulación con un Antagonista de la Vitamina K (Warfarina) para el Tratamiento del Tromboembolismo Venoso Agu...
    Medical condition: Tromboembolismo venoso (TEV) en pacientes con cáncer activo.
    Disease: Version SOC Term Classification Code Term Level
    12.1 10066899 Venous thromboembolism LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) DE (Completed) SK (Completed) CZ (Completed) AT (Completed) PT (Completed) IT (Completed) DK (Completed) GR (Completed) LV (Completed) BG (Completed)
    Trial results: View results
    EudraCT Number: 2009-015336-15 Sponsor Protocol Number: 29462 Start Date*: 2009-09-30
    Sponsor Name:Department of Vascular Medicine of the Academic Medical Center
    Full Title: Long-term treatment for cancer patients with deep vein thrombosis or pulmonary embolism - a randomized open label study
    Medical condition: Deep venous thrombosis or pulmonary embolism in patients with cancer
    Disease: Version SOC Term Classification Code Term Level
    12.0 10066899 Venous thromboembolism LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing) IT (Completed) DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2020-002282-33 Sponsor Protocol Number: COVID-PREVENT Start Date*: 2020-10-01
    Sponsor Name:Charité - Universitaetsmedizin Berlin
    Full Title: Effect of anticoagulation therapy on clinical outcomes in COVID-19 (COVID-PREVENT)
    Medical condition: Patients with moderate to severe COVID-19 disease which may cause acute cardiac injury
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-002270-29 Sponsor Protocol Number: IN 0401 INT Start Date*: Information not available in EudraCT
    Sponsor Name:LEO Pharma A/S
    Full Title: Safety profile of innohep versus subcutaneous unfractionated Heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis
    Medical condition: Treatment of acute deep vein thrombosis in elderly patients with impaired renal function
    Disease: Version SOC Term Classification Code Term Level
    6.1 10051055 LLT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended) ES (Completed) DK (Prematurely Ended) BE (Completed) CZ (Prematurely Ended) BG (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2012-004117-14 Sponsor Protocol Number: SPON1037-11 Start Date*: 2013-04-15
    Sponsor Name:Cardiff University
    Full Title: A feasibility study to inform the design of a randomised controlled trial to identify the most clinically and cost effective length of Anticoagulation with Low molecular weight heparin In the treat...
    Medical condition: Cancer Associated Thrombosis (CAT). Venous thromboembolism (VTE). Deep vein thrombosis (DVT). Pulmonary embolus (PE).
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004865 10049910 Thromboembolism prophylaxis LLT
    14.1 100000004866 10066899 Venous thromboembolism LLT
    14.1 100000004865 10013880 DVT prophylaxis LLT
    14.1 100000004855 10037380 Pulmonary embolus LLT
    14.1 100000004866 10043566 Thromboembolism LLT
    14.1 100000004855 10037436 Pulmonary thromboembolism LLT
    14.1 100000004865 10049909 Venous thromboembolism prophylaxis LLT
    14.1 100000004866 10013877 DVT LLT
    14.1 100000004866 10013878 DVT of calf LLT
    14.1 100000004866 10013879 DVT of legs LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2015-002340-14 Sponsor Protocol Number: REMAP-CAP Start Date*: 2015-09-16
    Sponsor Name:University Medical Center Utrecht
    Full Title: Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP). (COVID-19)
    Medical condition: Severe Community Acquired Pneumonia COVID-19
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10010120 Community acquired pneumonia LLT
    23.0 10021881 - Infections and infestations 10084268 COVID-19 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Trial now transitioned) IE (Trial now transitioned) PT (Trial now transitioned) GB (GB - no longer in EU/EEA) HU (Completed) BE (Trial now transitioned) DE (Ongoing) HR (Trial now transitioned) ES (Temporarily Halted) FR (Trial now transitioned) FI (Ongoing) IT (Trial now transitioned) CZ (Trial now transitioned) SI (Trial now transitioned) RO (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2014-000565-47 Sponsor Protocol Number: BAY59-7939/14372 Start Date*: 2014-07-25
    Sponsor Name:Bayer HealthCare AG
    Full Title: Multicenter, open-label, active-controlled, randomized study to evaluate the efficacy and safety of an age-and body weight-adjusted rivaroxaban regimen compared to standard of care in children with...
    Medical condition: Venous Thrombosis
    Disease: Version SOC Term Classification Code Term Level
    17.0 100000004866 10066899 Venous thromboembolism LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: ES (Completed) AT (Completed) IT (Completed) NL (Completed) BE (Completed) DE (Completed) GB (Completed) PL (Completed) IE (Completed) FR (Completed) FI (Completed) HU (Completed) SE (Completed) SK (Completed) PT (Completed)
    Trial results: View results
    EudraCT Number: 2014-000566-22 Sponsor Protocol Number: BAY59-7939/14374 Start Date*: 2014-07-11
    Sponsor Name:Bayer HealthCare AG
    Full Title: 30-day, single-arm study of the safety, efficacy and the pharmacokinetic and pharmacodynamic properties of oral rivaroxaban in young children with various manifestations of venous thrombosis
    Medical condition: Venous Thrombosis
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004866 10066899 Venous thromboembolism LLT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: IE (Completed) IT (Completed) ES (Completed) AT (Completed) NL (Completed) BE (Completed) GB (Completed) FR (Completed) HU (Completed) FI (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 04 16:38:17 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA